Scott Baumgartner Selected Research

2-(2,6-dioxopiperidin-3-yl)phthalimidine (EM 12)

1/2019

Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott Baumgartner Research Topics

Disease

16	Gout 01/2020 - 12/2014
4	Rheumatoid Arthritis 06/2015 - 05/2009
2	Hyperuricemia 11/2019 - 01/2018
2	Pain (Aches) 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 05/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2012 - 03/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2017
1	Hypertension (High Blood Pressure) 05/2017
1	Chronic Renal Insufficiency 05/2017
1	Hypersensitivity (Allergy) 10/2015
1	Exanthema (Rash) 10/2015
1	Neutropenia 03/2012
1	Nasopharyngitis 03/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2012
1	Erythema 03/2012
1	Necrosis 09/2010
1	Rheumatic Diseases (Rheumatism) 05/2009

Drug/Important Bio-Agent (IBA)

13	Uric Acid (Urate)IBA 01/2020 - 12/2014
9	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 10/2015
8	lesinuradIBA 01/2019 - 12/2014
5	Xanthine OxidaseIBA 01/2019 - 12/2014
4	Febuxostat FDA Link 01/2019 - 12/2014
3	Monoclonal AntibodiesIBA 06/2015 - 05/2009
2	brodalumabIBA 06/2015 - 03/2012
2	Infliximab (Remicade)FDA Link 09/2010 - 05/2009
2	Etanercept (Enbrel)FDA Link 09/2010 - 05/2009
2	Tumor Necrosis Factor InhibitorsIBA 09/2010 - 05/2009
1	verinuradIBA 11/2019
1	2-(2,6-dioxopiperidin-3-yl)phthalimidine (EM 12)IBA 01/2019
1	AcidsIBA 01/2018
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 05/2017
1	Interleukin-17 ReceptorsIBA 06/2015
1	Methotrexate (Mexate)FDA LinkGeneric 06/2015
1	Colchicine FDA LinkGeneric 12/2014
1	Indicators and Reagents (Reagents)IBA 03/2012
1	Biological ProductsIBA 12/2011
1	Adalimumab (Humira)FDA Link 09/2010
1	EnzymesIBA 09/2010
1	AntibodiesIBA 05/2009
1	Pharmaceutical PreparationsIBA 05/2009
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2009
1	Lymphotoxin-alpha (Lymphotoxin)IBA 05/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009

Therapy/Procedure

11	Therapeutics 01/2020 - 12/2014
1	Intra-Articular Injections 01/2018
1	Contraindications 12/2017